Lumos Pharma Inc. buy melinda
Start price
13.10.17
/
50%
€105.48
Target price
27.12.17
€144.00
Performance (%)
-30.46%
End price
27.12.17
€73.35
Summary
This prediction ended on 27.12.17 with a price of €73.35. Massive losses of -30.46% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Lumos Pharma Inc. | 43.269% | 43.269% | 17.323% | -53.071% |
iShares Core DAX® | 3.054% | -1.396% | 15.789% | 12.675% |
iShares Nasdaq 100 | 4.389% | -5.391% | 29.906% | 39.325% |
iShares Nikkei 225® | 5.386% | -3.105% | 16.065% | 8.150% |
iShares S&P 500 | 2.955% | -3.011% | 25.903% | 37.650% |
Comments by melinda for this prediction
In the thread NewLink Genetics Corp diskutieren
$
(Vom Mitglied beendet)
Stopped prediction by melinda for Lumos Pharma Inc.
Lumos Pharma Inc.
Start price
Target price
Perf. (%)
€95.14
13.10.17
13.10.17
€129.89
27.12.17
27.12.17
-30.46%
27.12.17
27.12.17
Lumos Pharma Inc.
Start price
Target price
Perf. (%)
€147.67
10.09.17
10.09.17
€194.83
11.09.17
11.09.17
-10.78%
11.09.17
11.09.17
Lumos Pharma Inc.
Start price
Target price
Perf. (%)
€52.12
14.06.17
14.06.17
€121.77
08.09.17
08.09.17
151.87%
08.09.17
08.09.17